tiprankstipranks
Cardiff Oncology, Inc. (CRDF)
NASDAQ:CRDF

Cardiff Oncology (CRDF) Technical Analysis

1,317 Followers

Technical Sentiment

Overall Consensus
Buy
14Bullish
4Neutral
4Bearish
Technical Analysis Consensus
Sell
2Bullish
4Neutral
4Bearish
Moving Average Consensus
Strong Buy
12Bullish
0Neutral
0Bearish
Cardiff Oncology, Inc.’s (CRDF) Moving Averages Convergence Divergence (MACD) indicator is 0.14, suggesting Cardiff Oncology, Inc. is a Sell.
Cardiff Oncology, Inc.’s (CRDF) 20-Day exponential moving average is 1.82, while Cardiff Oncology, Inc.’s (CRDF) share price is $2.91, making it a Buy.
Cardiff Oncology, Inc.’s (CRDF) 50-Day exponential moving average is 1.66, while Cardiff Oncology, Inc.’s (CRDF) share price is $2.91, making it a Buy.

Cardiff Oncology (CRDF) Pivot Points

Mar 04, 2024, 01:23 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
1.53
1.63
1.70
1.80
1.87
1.97
2.04
Fibonacci
1.63
1.70
1.74
1.80
1.87
1.91
1.97
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Cardiff Oncology (CRDF) Moving Averages

Mar 04, 2024, 01:23 PM
Period
Simple
Exponential
MA5
2.00Buy
2.14Buy
MA10
1.84Buy
1.95Buy
MA20
1.79Buy
1.82Buy
MA50
1.65Buy
1.66Buy
MA100
1.41Buy
1.56Buy
MA200
1.52Buy
1.58Buy
Cardiff Oncology, Inc.’s (CRDF) 10-Day exponential moving average is 1.95, while Cardiff Oncology, Inc.’s (CRDF) share price is $2.91, making it a Buy.
Cardiff Oncology, Inc.’s (CRDF) 100-Day exponential moving average is 1.56, while Cardiff Oncology, Inc.’s (CRDF) share price is $2.91, making it a Buy.
Cardiff Oncology, Inc.’s (CRDF) stock price is $2.91 and Cardiff Oncology, Inc.’s (CRDF) 50-day simple moving average is 1.65, creating a Buy signal.
Cardiff Oncology, Inc.’s (CRDF) stock price is $2.91 and Cardiff Oncology, Inc.’s (CRDF) 100-day simple moving average is 1.41, creating a Buy signal.
Cardiff Oncology, Inc.’s (CRDF) stock price is $2.91 and Cardiff Oncology, Inc.’s (CRDF) 200-day simple moving average is 1.52, creating a Buy signal.

Cardiff Oncology (CRDF) Technical Indicators

Mar 04, 2024, 01:23 PM
Name
Value
Implied Action
RSI (14)
83.96
Sell
STOCH (9,6)
62.91
Neutral
STOCHRSI (14)
65.19
Neutral
MACD (12,26)
0.14
Sell
ADX (14)
25.34
Neutral
Williams %R
-11.11
Sell
CCI (14)
516.22
Sell
ATR (14)
0.20
-
Ultimate Oscillator
65.20
Neutral
ROC
60.77
Buy
Cardiff Oncology, Inc.’s (CRDF) Relative Strength Index (RSI) is 83.96, creating a Sell signal.
Cardiff Oncology, Inc.’s (CRDF) Trend Strength Indicator (ADX) is 25.34, creating a Neutral signal.
Cardiff Oncology, Inc.’s (CRDF) Commodity Channel Index (CCI) is 516.22, creating a Sell signal.
Cardiff Oncology, Inc.’s (CRDF) Price Rate of Change (ROC) is 60.77, creating a Buy signal.

FAQ

Is CRDF a Buy, Hold, or Sell?
Based on CRDF’s technical indicators, CRDF is a Buy.
    What is CRDF’s RSI (14)?
    CRDF’s RSI (14) is 83.96, which suggests CRDF is a Sell.
      What is CRDF’s MACD?
      CRDF’s MACD is 0.14, which suggests CRDF is a Sell.
        What is CRDF’s 5-day moving average?
        CRDF’s 5-day moving average is 2.00, which suggests CRDF is a Buy.
          What is CRDF’s 20-day moving average?
          CRDF 20-day moving average is 1.79, which suggests CRDF is a Buy.
            What is CRDF’s 50-day moving average?
            CRDF’s 50-day moving average is 1.65, which suggests CRDF is a Buy.
              What is CRDF’s 200-day moving average?
              CRDF’s 200-day moving average is 1.52, which suggests CRDF is a Buy.
                What is CRDF’s Williams % R (14)?
                CRDF’s Williams % R (14) is -11.11, which suggests CRDF is a Sell.
                  What is CRDF’s CCI (14)?
                  CRDF’s CCI (14) is 516.22, which suggests CRDF is a Sell.
                    What's Included in PREMIUM?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis